Gefitinib (Iressa)
Drug timelines are a Plus or Pro feature.
18 regulatory and trial events tracked for Gefitinib (Iressa), covering 2007-12-18 to 2018-03-15. Get the full timeline:
Most recent: Clinical Trial Update: Secondary Primary Tumor Prevention With EGFR, OSI-774, and Cyclooxygenase-2 [Phase 1]